Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study by Drake, TM, Fairfield, C, Pius, R, Et al.

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, pr... by Russell, CD, Fairfield, CJ, Drake, TM, Turtle, L, Seaton, RA, Wootton, DG, Sigfrid, L, Harrison, EM, Docherty, AB, de Silva, TI, Egan, C, Pius, R, Hardwick, HE, Merson, L, Girvan, M, Dunning, J, Nguyen-Van-Tam, JS, Openshaw, PJM, Baillie, JK, Semple, MG, Ho, A, ISARIC4C investigators, Horby, PW

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study by Docherty, AB, Harrison, EW, Green, CA, Hardwick, HE, Pius, R, Norman, L, Holden, KA, Read, JM, Dondelinger, F, Carson, G, Merson, L, Lee, J, Plotkin, D, Sigfrid, L, Halpin, S, Jackson, C, Gamble, C, Horby, PW, Nguyen-Van-Tam, JS, Ho, A, Russell, CD, Dunning, J, Openshaw, PJ, Baillie, JK, Semple, MG, ISARIC4C investigators

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score by Knight, SR, Ho, A, Pius, R, Buchan, I, Carson, G, Drake, TM, Dunning, J, Fairfield, CJ, Gamble, C, Green, CA, Gupta, R, Halpin, S, Hardwick, HE, Holden, KA, Horby, PW, Jackson, C, Mclean, KA, Merson, L, Nguyen-Van-Tam, JS, Norman, L, Noursadeghi, M, Olliaro, PL, Pritchard, MG, Russell, CD, Shaw, CA, Sheikh, A, Solomon, T, Sudlow, C, Swann, OV, Turtle, LCW, Openshaw, PJM, Baillie, JK, Semple, MG, Docherty, AB, Harrison, EM

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. by Drake, TM, Riad, AM, Fairfield, CJ, Egan, C, Knight, SR, Pius, R, Hardwick, HE, Norman, L, Shaw, CA, McLean, KA, Thompson, AAR, Ho, A, Swann, OV, Sullivan, M, Soares, F, Holden, KA, Merson, L, Plotkin, D, Sigfrid, L, de Silva, TI, Girvan, M, Jackson, C, Russell, CD, Dunning, J, Solomon, T, Carson, G, Olliaro, P, Nguyen-Van-Tam, JS, Turtle, L, Docherty, AB, Openshaw, PJ, Baillie, JK, Harrison, EM, Semple, MG

Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol by Knight, SR, Gupta, RK, Ho, A, Pius, R, Buchan, I, Carson, G, Drake, TM, Dunning, J, Fairfield, CJ, Gamble, C, Green, CA, Halpin, S, Hardwick, HE, Holden, KA, Horby, PW, Jackson, C, Mclean, KA, Merson, L, Nguyen-Van-Tam, JS, Norman, L, Olliaro, PL, Pritchard, MG, Russell, CD, Shaw, CA, Sheikh, A, Solomon, T, Sudlow, C, Swann, OV, Turtle, LCW, Openshaw, PJM, Baillie, JK, Docherty, A, Semple, MG, Noursadeghi, M, Harrison, EM

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study by Gupta, RK, Harrison, EM, Ho, A, Docherty, AB, Knight, SR, van Smeden, M, Abubakar, I, Lipman, M, Quartagno, M, Pius, R, Buchan, I, Carson, G, Drake, TM, Dunning, J, Fairfield, CJ, Gamble, C, Green, CA, Halpin, S, Hardwick, HE, Holden, KA, Horby, PW, Jackson, C, Mclean, KA, Merson, L, Nguyen-Van-Tam, JS, Norman, L, Olliaro, PL, Pritchard, MG, Russell, CD, Scott-Brown, J, Shaw, CA, Sheikh, A, Solomon, T, Sudlow, C, Swann, OV, Turtle, L, Openshaw, PJM, Baillie, JK, Semple, MG, Noursadeghi, M, ISARIC4C Investigators

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK by Docherty, AB, Mulholland, RH, Lone, NI, Cheyne, CP, De Angelis, D, Diaz-Ordaz, K, Donegan, C, Drake, TM, Dunning, J, Funk, S, García-Fiñana, M, Girvan, M, Hardwick, HE, Harrison, J, Ho, A, Hughes, DM, Keogh, RH, Kirwan, PD, Leeming, G, Nguyen Van-Tam, JS, Pius, R, Russell, CD, Spencer, RG, Tom, BDM, Turtle, L, Openshaw, PJM, Baillie, JK, Harrison, EM, Semple, MG, Baillie, JK, Semple, MG, Openshaw, PJM, Carson, G, Alex, B, Bach, B, Barclay, WS, Bogaert, D, Chand, M, Cooke, GS, Docherty, AB, da Silva Filipe, A, Fletcher, T, Green, CA, Harrison, EM, Hiscox, JA, Ho, AYW, Horby, PW, Ijaz, S, Khoo, S

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study by Närhi, F, Moonesinghe, SR, Shenkin, SD, Drake, TM, Mulholland, RH, Donegan, C, Dunning, J, Fairfield, CJ, Girvan, M, Hardwick, HE, Ho, A, Leeming, G, Nguyen-Van-Tam, JS, Pius, R, Russell, CD, Shaw, CA, Spencer, RG, Turtle, L, Openshaw, PJM, Baillie, JK, Harrison, EM, Semple, MG, Docherty, AB, Openshaw, PJ, Carson, G, Alex, B, Andrikopoulos, P, Bach, B, Barclay, WS, Bogaert, D, Chand, M, Chechi, K, Cooke, GS, da Silva Filipe, A, de Silva, T, dos Santos Correia, G, Dumas, ME, Fletcher, T, Green, CA, Greenhalf, W, Griffin, J, Gupta, RK, Hiscox, JA, Ho, AY, Horby, PW, Ijaz, S, Khoo, S, Klenerman, P, Law, A, Lewis, M, Mentzer, AJ, Sigfrid, L